Clinical Trial Update: The Treatment of Coronary De-novo Lesions With the Elutax Paclitaxel-eluting Balloon Alone, a Pilot Study [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial evaluating the Elutax paclitaxel-eluting balloon used alone for de-novo coronary lesions has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Stenosis
• Stable Angina

Drugs mentioned

• Elutax Paclitaxel-eluting Balloon (paclitaxel-coated balloon)

Snippet

Sponsor: Aalborg University Hospital | Conditions: Stable Angina, Coronary Stenosis | Phase 4 | Status: TERMINATED